A Next-Generation approach to Quality Control in drug product development

Introduction

Developing oral solid dosage (OSD) forms is complex. Traditional quality control methods often slow you down and increase risk. Our latest white paper reveals how CUB-X, a next-generation inspection system, transforms quality control with real-time, non-destructive analysis of critical quality attributes. Learn how to accelerate development, reduce waste, and ensure compliance from lab to production.

The challenge behind OSD development

Formulation teams face challenges such as poor API solubility, limited early data, and slow detectability studies. Scaling up can expose hidden variability and increase regulatory demands for deeper process understanding. Relying on destructive, time-consuming methods adds cost and complexity, making real-time monitoring tools like Process Analytical Technology (PAT) essential for achieving Quality by Design (QbD).

Download the full article to explore:

• Why traditional QC methods fall short
• How CUB-X integrates advanced spectroscopy, laser profiling, and mechanical testing
• Practical benefits for R&D, clinical, and commercial stages

Get access to the article by filling out the form below